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Abstract
The association between fatigue and sarcopenia is not well understood, therefore, this study aimed to compare the sarcopenia measures among elderly with
mild and severe fatigue and to determine whether fatigue severity is associated with sarcopenia measures. This was a cross-sectional study conducted on
201 elderly (age = 68.45±6.30 years). The elderly was classified into either mild or severe fatigue based on the Fatigue Severity Scale (FSS), meanwhile, sar-
copenia measures include SARC-F score, muscle mass (ASM/height2), calf circumference (CC), upper (handgrip) and lower limb muscle strength, as well as
physical performance (gait speed). Data were analyzed using independent t-tests and logistic regression. The results showed that elderly with severe fatigue
were significantly older, with lower muscle strength, and slower gait speed (all p-value <0.05). After adjusting for age, fatigue severity remained significantly
associated with SARC-F score (OR = 1.583, 95% CI = 1.262-1.986, p-value = 0.001) and CC (OR = 1.103, 95% CI = 1.014-1.200, p-value = 0.022). Moreover,
when the SARC-F score was removed from the regression model, fatigue severity was significantly associated with CC (OR = 1.088, 95% CI = 1.006-1.178,
p-value = 0.036) and gait speed (OR = 0.011, 95% CI = 0.001-0.168, p-value = 0.001). Based on the results, fatigue severity is associated with SARC-F score,
CC, and gait speed, therefore, interventions targeted at sarcopenia measures is recommended to optimize physical endurance in the elderly.
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Introduction
Fatigue is a common self-reported distressing symp-
tom, perceived as a lack of energy or a feeling of exhaus-
tion accompanying the aging process,1 it affects more
than 20% of the community-dwelling elderly.2,3
Meanwhile, sarcopenia is defined as a generalized muscle
weakness which may have a role in the development of
fatigue in the elderly. Globally, sarcopenia shows some
tendencies toward a greater use or burden on healthcare
resources in the population,4 due to its potential associa-
tion with fatigue and malnutrition,5,6 which results in
poor life quality and frailty syndrome in the long run.7
Previous findings on the association between fatigue
and sarcopenia were inconsistent as different assessment
tools have been used. For instance, a population-based
study in Brazil found that self-reported fatigue using the
Centre for Epidemiologic Studies-Depression (CES-D)
Scale was associated with physical performances as indi-
cated by the Short Physical Performance Battery (SPPB)
and normal gait speed after adjusting covariates.3 In con-
trast, another study reported no association between fa-
tigue and any criteria used to define sarcopenia.8 In the
latter study, fatigue symptom was assessed by inquiring
“In the last week, how many times have you felt that
everything you do is an effort?” with four possible an-
swers: (a) rarely, (b) few times, (c) occasionally, and (d)
most of the time. The lack of association is probably due
to the use of inadequate assessment, sufficient to opera-
tionalize the perception of fatigue in the elderly.
Furthermore, a study found no significant differences
in self-reported fatigue among non-sarcopenic and sar-
copenic patients with osteoarthritis and rheumatoid
arthritis. In the study, fatigue was measured using the
Multidimensional Assessment of Fatigue and Visual
Analog Scale.9 Besides, the sarcopenia status of the par-
ticipants was diagnosed based on the appendicular skele-
tal  muscle mass (AMI), meanwhile, based on the results,
there was no significant association with self-reported fa-
tigue or physical function.9 Self-reported fatigue assess-
ment using Fatigue Severity Scale (FSS) might be a better
option for the elderly as the scale measures the severity
of fatigue and its effect on individual activities and
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lifestyle with 9-items.10 Furthermore, the FSS has been
reported to have low floor and moderate ceiling effects.11
In comparison, the CES-D scale is related to symptoms
associated with depression,12 while the Multidimensional
Assessment is a 16-item scale and might take a longer
time to be completed.13
Recently, the European Working Group for
Sarcopenia in Older People (EWGSOP),14 and the Asian
Working Group for Sarcopenia (AWGS),15 suggested
that measures of sarcopenia includes finding cases using
the SARC-F questionnaire, muscle mass (MM), and
strength, as well as physical performances. Also, AWGS
suggested that sarcopenia is also determined by measur-
ing the calf circumference (CC) as a proxy for MM in the
absence of other tools.15 Identifying which measures in-
fluence the severity of fatigue using a more practical as-
sessment scale is important as it promote rehabilitation
for the elderly with physical intolerance especially when
performing daily activities. This study aimed to compare
the sarcopenia measures among elderly with mild and se-
vere fatigue and to determine whether fatigue severity is
associated with sarcopenia measures. 
Method
This was a cross-sectional study conducted on 201
community-dwelling elderly aged 60 years and above
from 10 selected villages in Selangor from November
2019 to January 2020. Meanwhile, Selangor was selected
because it is one of the states with the highest elderly
population in Malaysia.16 Participants were included de-
pending on the ability to understand Malay or English as
well as verbal instruction, and provided the Mini-cog
score is above four.17 In addition, participants with se-
vere hypertension (systolic blood pressure >180 during
screening or recruitment), unable to understand the
study procedure, with underlying medical problems, and
undergone surgical procedure (less than six months be-
fore screening) were excluded. Eligible participants com-
pleted the questionnaires for biomedical examination and
socio-demographic profile, meanwhile each partici pant
was required to sign an informed consent before data col-
lection while an ethics approval was obtained from the
Research Ethics Committee of Universiti Teknologi
MARA (Approval No. REC/493/19). Besides, data such
as age, gender, and health history were gathered through
self-reported or assisted questionnaires. Bodyweight was
measured by a calibrated scale, and height was assessed
with a measuring tape fixed on a wall.
The Fatigue Severity Scale (FSS) was used to assess
the participants’ level of self-reported fatigue consisting
of 9-item in relation to how the level of fatigue causes
disturbances in physical function, continuous physical,
work, or social activities. The minimum possible score is
0, while the maximum possible score is 63. Moreover,
the participants were categorized into mild and severe
fatigue based on the cut-off score >36, which indicates
severe fatigue.18
Based on the AWGS algorithm recommendation,15
the following sarcopenia measures were included SARC-
F questionnaire, muscle mass (MM), calf circumference
(CC), upper (handgrip), and lower limb muscle strength,
as well as physical performance (gait speed). The SARC-
F questionnaire is a series of questions on capability, and
difficulty in performing specific tasks such as lifting and
carrying objects weighing 10 pounds, walking across a
room, transferring from a chair to a bed or vice versa,
climbing a flight of ten stairs, and the number of falls in
the previous year. Furthermore, the scores is graded as 0
having no difficulty, 1 as having some difficulty, and 2 as
a lot of difficulties to perform the task. A score of ≥4 in-
dicates the possibilities of sarcopenia.19
The bioimpedance analysis was used to assess MM by
measuring the appendicular skeletal muscle mass (ASM)
and recorded in kg. Thereafter, the score was then con-
verted to appendicular skeletal muscle index (ASMI)
[ASM/height2 (kg/m2)]. The cutoffs for low MM in sar-
copenia diagnosis were as follows, <7.0 kg/m2 in male,
and <5.7 kg/m2 in female.15 Besides, CC was measured
using a non-elastic tape on both calves in a standing po-
sition. The score was recorded based on the highest value
of either side of the calves. Meanwhile, cut-off values of
<34 cm and <33 cm were used for male and female res -
pectively, for possible sarcopenia.15
Handgrip strength was assessed to determine the up-
per limb (UL) muscle strength using a Jamar hand-held
dynamometer. The participants were positioned in sitting
position with the elbow in 90° flexion, while the wrist
and forearm in a neutral angle. Participants were asked
to grip (with the dominant side) the dynamometer as
strong as possible for three trials with a 1-min rest inter-
val.20 The score was recorded based on the best perform-
ance among the trials. The cut-off points for grip strength
were <28 kg and <18 kg for male and female respectively
for possible sarcopenia.15 The lower limb (LL) strength
was measured using the Five Times Sit-to-Stand Test
(FSTS) while the time taken to complete the test was
recorded. When participants takes more than 12 seconds
to complete the task, this indicate possible sarcopenia.15
Physical performance was evaluated based on the nor-
mal gait speed (m/s) using the 4-meter walk test
(4MWT). The participants performed 8-meter walk with
2-meter for the acceleration phase and another 2-meter
for the deceleration phase. Moreover, the time taken was
noted when participants have passed through the first 2-
meter and stop before the last 2-meter, hence, measuring
only 4-meter.21 The cut-off for gait speed was <1.0 m/s,
indicating possible sarcopenia.15
Statistical analysis was carried out using SPPS
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Version 25 (IBM Corp., New York, USA). Meanwhile,
the independent t-test was used to compare the charac-
teristics and sarcopenia measures between participants
with mild and severe fatigue. The multivariate logistic re-
gression was performed to test the association between
self-reported fatigue and sarcopenia measures based on
three models. Model 1 was the unadjusted model, Model
2 was performed by adjusting age, while Model 3 was
carried out by removing the SARC-F score from the mo -
del but with age-adjusted. All statistical significance was
set at p-value <0.05.
Results
A total of 201 elderly were recruited for this study
with a mean age of 68.45±6.30 years. Meanwhile, 57
(28.36%) elderly were found to report severe fatigue.
Comparisons among elderly with mild and severe fatigue
in terms of age, anthropometric data, and sarcopenia
measures are shown in Table 1. Participants that reported
severe fatigue were significantly older with heavier
weight, higher body mass index (BMI) and SARC-F
score, lower handgrip (upper limb) and lower limb
strength, as well as slower gait speed (all p-value <0.05). 
The association between fatigue severity and sarcope-
nia measures is shown in Table 2. In Model 1 for unad-
justed logistic regression analysis, fatigue severity was
significantly associated with SARC-F score (OR = 1.584,
95% CI = 1.263-1.986, p-value = 0.001) and CC (OR =
1.101, 95% CI = 1.012-1.205, p-value = 0.025).
Meanwhile, in Model 2 after adjusting for age, fatigue
severity remained significantly associated with SARC-F
score (OR = 1.583, 95% CI = 1.262-1.986, p-value =
0.001) and CC (OR = 1.103, 95% CI = 1.014-1.200, p-
value = 0.022). Model 3 was performed by removing the
SARC-F score, while analysis showed CC (OR = 1.088,
95% CI = 1.006-1.178, p-value = 0.036) and gait speed
(OR = 0.011, 95% CI = 0.001-0.168, p-value = 0.001)
were significantly associated with fatigue severity after
adjusting for age. 
Discussion
Based on the results, there was an association be-
tween self-reported fatigue and sarcopenia measures
(SARC-F score, MM, CC, upper (handgrip), and lower
Table 1. Comparisons of Characteristics among Elderly with Mild and Severe Fatigue (n = 201) 
                                                                                                (Mean ± SD)
Variable                                                                                                                                                                                      p-value
                                                  Total (n = 201)                  Mild Fatigue (n = 144)          Severe Fatigue (n = 57)
Age                                                 68.45±6.30                               67.65±5.89                             70.46±6.87                          0.004**
Gender                                                                                                                                                                                          0.499
Male                                                         97                                             70                                           27
Female                                                   104                                             74                                           30                                       
Height (cm)                                  160.22±9.26                             159.91±9.23                           161.00±9.38                              0.456
Weight (kg)                                  69.08±13.21                             67.05±12.45                           74.23±13.95                          0.001**
Body mass index (kg/m2)               26.91±4.67                            26.15 ± 4.10                             28.82±5.45                          0.001**
SARC-F score                                   1.77±2.04                                 1.19±1.61                               3.21±2.28                          0.001**
MM (ASM/height2)                          6.44±1.31                                 6.46±1.31                               6.38±1.32                              0.709
CC (cm)                                         33.99±5.33                               34.02±4.95                          35.60 ± 6.19                              0.060
UL strength (kg)                        25.34±11.028                             26.35±11.32                             22.77±9.86                            0.038*
LL strength (s)                               14.59±6.94                               13.68±6.95                             16.87±6.43                            0.038*
Gait speed (m/s)                              0.54±0.18                                 0.57±0.16                               0.44±0.17                          0.001**
Notes: CC: Calf Circumference; UL: Upper Limb; LL: Lower Limb; ASM: Appendicular Skeletal Muscle Mass, SD: Standard
Deviation. Independent t-test; *significant at p-value < 0.05; **significant at p-value < 0.01. The gender difference was compared
using a χ2 test.
Table 2. Multivariate Models for the Association of Sarcopenia Measures and Self-Reported Fatigue Severity among Elderly (n = 201) 
                                                      Model 1                                                             Model 2                                                        Model 3
Variable
                                 OR             95% CI           p-value                   OR              95% CI             p-value                  OR                95% CI            p-value
SARC-F score          1.584        1.263-1.986       0.001**                 1.583          1.262-1.986         0.001**                        -                             -                   -
MM                         0.842        0.588-1.205           0.346                 0.861          0.589-1.241            0.422                 0.898          0.635-1.271           0.545
CC                           1.101        1.012-1.197         0.025*                 1.103          1.014-1.200           0.022*                 1.088          1.006-1.178          0.036*
UL strength            1.017        0.978-1.058           0.397                 1.016          0.976-1.057            0.164                 0.995          0.959-1.032           0.777
LL strength             0.994        0.938-1.054           0.831                 0.993          0.937-1.052            0.801                 0.999          0.948-1.052           0.966
Gait speed               0.119        0.007-2.068           0.226                 0.170          0.008-3.419            0.358                 0.011          0.001-0.168        0.001**
Notes: Model 1: Univariate analysis; Model 2: adjusted for age; Model 3: adjusted for age with SARC-F score removed.
CC: Calf Circumference; UL: Upper Limb; LL: Lower Limb; OR: Odds Ratio; CI: Confidence Interval. 
*significant at p-value <0.05; **significant at p-value <0.01
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limb strength, as well as gait speed). The prevalence of
fatigue was 28.36%, which was higher compared to pre-
vious report measured using the CES-D scale in the com-
munity,3 but lower compared to a report in the institu-
tion measured using FSS.22 For the unadjusted model,
only SARC-F score and CC were associated with self-re-
ported fatigue. Meanwhile, after adjusting for age, the
SARC-F score and CC remained significantly associated
with fatigue severity. Model 3, which excluded the
SARC-F score, but age-adjusted, showed that CC and
gait speed were significantly associated with fatigue
severity.
Furthermore, the results showed that elderly with se-
vere fatigue have significantly higher SARC-F scores,
weaker muscle strength (UL and LL), and slower gait
speed. SARC-F was found to be consistently associated
with fatigue even after adjustment for age. A previous
study on cancer patients also found that fatigue, known
to be related to cancer diagnosis and treatment, was sig-
nificantly associated with the SARC-F score.23 This was
expected as the SARC-F questionnaire asked for the par-
ticipants’ performance on specific physical activities simi -
lar to the FSS which made both methods to be associated. 
Regarding MM, measured using the bioelectrical im-
pedance analysis (BIA), together with CC as a proxy for
MM, there was no significant differences between elderly
with mild and fatigue severity. This is probably due to
the physiological decline resulting from aging process in
the elderly. However, CC was consistently associated
with fatigue severity in all the regression models. In con-
trast to a previous study, MM based on the skeletal mus-
cle index was found to predict the le vel of fatigue.24 This
inconsistent result is probably because the participants
in the previous study had cancer-related fatigue which
might have a different mechanism of fatigue and sarcope-
nia, or in other words, the sarcopenia is due to secondary
causes.24 Secondary sarcopenia occurs as a result of both
depletion of fat and muscular tissue either due to lack of
vitamin D, insufficient food intake, decrease physical ac-
tivity secondary to fatigue, as well as outcome of a direct
effect of chemotherapy on muscular tissue.25 Meanwhile,
sarcopenia in the elderly primarily occurs due to changes
in aging throughout life where there is a progressive de-
cline in skeletal muscle strength and MM.26 Neefjes, et
al.,24 found no significant differences in the level of fa-
tigue with increased MM in women with advanced cancer
signifying the probability of other factors that contribute
to fatigue. It has been argued that exercise induces an-
giogenesis, thereby improving blood supply to the mus-
cles,27 hence, promote recovery of muscle fatigue.28 The
result was not in line with a previous study that found no
significant relationship between muscle strength and fa-
tigue level.29 Meanwhile, this was expected as this study
recruited individuals with Parkinson's disease which
have a different underlying mechanism.29
This study also showed that the muscle strength of
the UL and LL in the elderly with severe fatigue was sig-
nificantly lower. The results were consistent with a pre-
vious study which reported a significant decline in grip
strength (p-value <0.01) in the elderly that complained
of fatigue resulting in reduced physical performance.30
Besides, LL strength was also found to be lower in a pre-
vious study that used the 5-Step Test to measure the time
(in second). It took five times, for the participants to go
up and down a 10.1 cm wooden platform. Similar ly,
Gacesa, et al.,31 observed a decremental pattern in the
level of muscle fatigue as opposed to an incremental pat-
tern in muscle strength following four weeks of strength
training (fatigue decreased from 38.9+8.6% to
12.4+0.7%; muscle strength increased from
660.0+112.3% to 839.5+125.5%, respectively). The re-
sults showed a significant association between fatigue
level and muscle strength indicating that a higher level of
muscle strength results in a lower level of fatigue. This is
in line with the current study which found a lower level
of fatigue in the elderly with a higher LL strength.
Strength training causes an increase in skeletal muscle
adaptations, which resultantly increase muscle ability to
generate power and force to execute functional tasks
thereby decreasing fatigue.31
Furthermore, increased recruitment of new motor
units along with an increase in cellular metabolic control
improves the energy level and efficiency of energy con-
sumption necessary for muscle contractions.31 In con-
trast, this study found that none of these muscle strength
measures were significantly associated with fatigue sever-
ity. Measuring LL strength using the FSTS was not rec-
ommended by the AWGS as it tends to reflect multicom-
plex pathologies.15 Therefore, it is suggested that meas-
ures of strength must not directly influence fatigue sever-
ity as the item asked in FSS including physical function
as well as physical, work, and social activities are more
geared towards physical performance. This also explains
why the SARC-F score and gait speed were more likely
to be associated with fatigue severity as the measures in-
dicate activities related to physical performances.23
Concerning gait speed, the elderly that reported fa-
tigue took a longer time to complete the test indicating
lower physical performance. This was supported by a
previous study which found that gait speed as one of the
components in the SPPB scale was associated with self-
reported fatigue, however, in this study, fatigue was
measured based on the CES-D scale.3 These findings oc-
cured because the elderly that reported fatigue tend to
have reduced walking speed, which might also be due to
weakness of the lower limb as shown by a longer time
complete the test which resultantly led to a reduced mus-
cle force production needed to initiate walking move-
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ment. Hence, fatigue is an essential factor which directly
or indirectly affect the elderly’s physical performances.
Based on the results, there was a difference in the level of
fatigue and physical performance (gait speed) in line with
a previous study reported that elderly who complained of
fatigue display poorer health and lower physical perform-
ance compared to non-fatigued.32
There are a few limitations that need to be addressed
in this study. The small sample size makes it difficult to
find significant differences between fatigue and sarcope-
nia among the elderly. In addition, the participants con-
sisted of only 201 elderlies from a few selected locations
in Selangor, Malaysia, hence, the findings from this study
is not generalizable to all entire elderly population in
Malaysia as the level of fatigue might be affected by se -
condary factors such as pain, long-term medical illnesses,
emotional distress or personal lifestyles.33 Also, causali-
ties are not assumable as this is a cross-sectional study.
The purposeful sampling method was used to collect data
hence, the results might not be the actual representation
of the populations. In future studies, fatigue is expected
to be conceptualized through two different definitions,
namely perception of fatigue and as well as, fatigability
and objective changes that occur in response to neuro-
muscular system activation.34
Conclusion
In conclusion, fatigue severity is associated with per-
ceived sarcopenia as measured by the SARC-F question-
naire, CC and gait speed. The severely fatigued elderly
demonstrate lower muscle mass, higher SARC-F score,
lower muscle strength, and slower gait speed. In addition,
muscle mass and gait speed are associated with fatigue.
The findings of this study have implication on the prac-
tice of physiotherapists to include sarcopenia and fatigue
measures when dealing with elderly. Intervention for
elder ly should also target the sarcopenia indicators to im-
prove the physical tolerance or to reduce the perception
of fatigue.
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